Glycine receptor alpha-2 antibody

Principal name

Glycine receptor alpha-2 antibody

Alternative names for Glycine receptor alpha-2 antibody

GLRA2

SwissProt ID

P22771 (Rat), P23416 (Human), Q7TNC8 (Mouse)

Gene ID

2742 (GLRA2)

Available reactivities

Hu (Human), Ms (Mouse), Rt (Rat)

Available hosts

Rabbit

Available applications

Paraffin Sections (P), Western blot / Immunoblot (WB), Enzyme Immunoassay (E)

Background of Glycine receptor alpha-2 antibody

Transient overexpression lysate of glycine receptor, alpha 2 (GLRA2), transcript variant 1

9 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

Glycine receptor alpha-2 antibody

Sample (30 ug of whole cell lysate). A: 293T. B: A431. C: HepG2. 10% SDS PAGE. TA308886 diluted at 1:5000. Rabbit IgG Aff - Purified Hu, Ms P, WB
0.1 ml / €325.00
  OriGene Technologies, Inc.

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

Glycine receptor alpha-2

Glycine receptor alpha-2 Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
10 µg / €380.00
  Abnova Taiwan Corp.

Glycine receptor alpha-2

Glycine receptor alpha-2 Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
25 µg / €510.00
  Abnova Taiwan Corp.

Glycine receptor alpha-2

Glycine receptor alpha-2 Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
10 µg / €380.00
  Abnova Taiwan Corp.

Glycine receptor alpha-2

Glycine receptor alpha-2 Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
25 µg / €510.00
  Abnova Taiwan Corp.

Lysates

Catalog No.    

GLRA2 overexpression lysate

GLRA2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

GLRA2 overexpression lysate

GLRA2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

GLRA2 overexpression lysate

GLRA2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

GLRA2 overexpression lysate

GLRA2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

9 Item(s)

per page
  • LinkedIn